Skip to main content
. 2021 May 11;24(4):470–480. doi: 10.4103/aian.AIAN_20_21

Table 2.

Summary of conditions other than epilepsy with probable/ possible benefit from KDT [Adapted from Kossoff et al.][81]

Conditions where KD is beneficial with >70% response
 Angelman syndrome
 Complex I mitochondrial disease
 Glucose-1 transporter deficiency syndrome
 PDH deficiency
Conditions where KD is beneficial with 40-70% response (based on one case report or case series)
 Adenylosuccinate lyase deficiency
 CDKL5 encephalopathy
 Glycogenosis type V
 Lafora body disease
 Phosphofructokinase deficiency
 Rett syndrome
 Subacute sclerosing panencephalitis (SSPE)